UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

British journal of clinical pharmacology, 2021-12, Vol.87 (12), p.4658-4669

2021

Link zum Volltext

Verfügbarkeit prüfen

Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI: Protocol development, multicenter feasibility, and repeatability

Muscle & nerve, 2022-08, Vol.66 (2), p.183-192

2022

Link zum Volltext

Verfügbarkeit prüfen

Recovery-Oriented Service Provision and Clinical Outcomes in Assertive Community Treatment

Psychiatric rehabilitation journal, 2011, Vol.34 (3), p.194-201

2011

Link zum Volltext

Verfügbarkeit prüfen

Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card

Pharmacology research & perspectives, 2020-02, Vol.8 (1), p.e00555-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials

Thrombosis research, 2008, Vol.123 (1), p.24-34

2008

Link zum Volltext

Verfügbarkeit prüfen

Comparison of generalized estimating equations and quadratic inference functions using data from the National Longitudinal Survey of Children and Youth (NLSCY) database

BMC medical research methodology, 2008-05, Vol.8 (1), p.28-28, Article 28

2008

Link zum Volltext

Verfügbarkeit prüfen

Parenting-by-gender interactions in child psychopathology: attempting to address inconsistencies with a Canadian national database

Child and adolescent psychiatry and mental health, 2010-01, Vol.4 (1), p.5-5, Article 5

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy

AIDS (London), 2010-07, Vol.24 (12), p.1857-1865

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

Lancet neurology, 2024-05, Vol.23 (5), p.477-486

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study

AIDS research and therapy, 2009-06, Vol.6 (1), p.11-11

2009

Link zum Volltext

Verfügbarkeit prüfen

Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3810-3816

2008

Link zum Volltext

Verfügbarkeit prüfen

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial

Vaccine, 2017-01, Vol.35 (2), p.395-402

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

Canadian Medical Association journal (CMAJ), 2017-10, Vol.189 (41), p.E1276

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vaccine 35 (2017) 395–402]

Vaccine, 2017-05, Vol.35 (24), p.3279-3279

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]

Vaccine, 2017-05, Vol.35 (24), p.3279-3279

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial

Vaccine, 2017-01, Vol.35 (2), p.395-402

2017

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

Clinical infectious diseases, 2012-06, Vol.54 (12), p.1798-1805

2012

Link zum Volltext

Verfügbarkeit prüfen

Mentoring in biostatistics: some suggestions for reform

Journal of multidisciplinary healthcare, 2012-01, Vol.5 (default), p.265-272

2012

Link zum Volltext

Verfügbarkeit prüfen

Tips on overlapping confidence intervals and univariate linear models

Nurse researcher, 2009, Vol.16 (4), p.73

2009

Link zum Volltext

Verfügbarkeit prüfen

Methodological and clinical issues in analysis of data from HIV cardiovascular research: Validity of ultrasound methods, impact of anti-retroviral therapy on atherosclerosis, and imputation of missing values

Odueyungbo, Adefowope

2010

Link zum Volltext

Verfügbarkeit prüfen

On the distribution of dam content for a dam operating in discrete time

Odueyungbo, Adefowope Olorunwa

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(19)
Dissertationen
(2)

Sprache

Englisch
(21)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(12)
Female
(7)
Male
(7)
Adult
(4)
Biological And Medical Sciences
(4)
Clinical Trials
(4)
Medical Sciences
(4)
Middle Aged
(4)
Analysis Of Variance
(3)
Child, Preschool
(3)
Hiv
(3)
Immunology
(3)
Patients
(3)
Randomized Controlled Trials As Topic
(3)
4cmenb
(2)
Age
(2)
Age Factors
(2)
Aged
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Quantitative muscle analysis in facioscapulohumeral muscular dystrophy using whole‐body fat‐referenced MRI: Protocol development, multicenter feasibility, and repeatability

Recovery-Oriented Service Provision and Clinical Outcomes in Assertive Community Treatment

Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card

Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials

Comparison of generalized estimating equations and quadratic inference functions using data from the National Longitudinal Survey of Children and Youth (NLSCY) database

Parenting-by-gender interactions in child psychopathology: attempting to address inconsistencies with a Canadian national database

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy

Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial

Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study

Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vaccine 35 (2017) 395–402]

Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

Mentoring in biostatistics: some suggestions for reform

Tips on overlapping confidence intervals and univariate linear models

Methodological and clinical issues in analysis of data from HIV cardiovascular research: Validity of ultrasound methods, impact of anti-retroviral therapy on atherosclerosis, and imputation of missing values

On the distribution of dam content for a dam operating in discrete time

Suchergebnisse filtern